GlassScriptPhysician profile
Parth R Parikh
NPI 1851706717
$2,374.12
in general payments reported to CMS, 2019-2025
11 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2021: $125 · 2022: $474 · 2023: $568 · 2024: $672 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,373.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $557.41 | 2022-2024 | Xarelto |
| Inari Medical, INC. | $549.83 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $401.75 | 2019 | |
| Novartis Pharmaceuticals Corporation | $190.65 | 2022-2024 | |
| Boston Scientific Corporation | $188.21 | 2022-2024 | Watchman Flx |
| Amgen INC. | $133.75 | 2025 | Krystexxa |
| Glaxosmithkline, LLC. | $124.99 | 2021 | |
| Abiomed | $93.75 | 2023 | Impella |
| Pfizer INC. | $54.53 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $43.74 | 2023-2024 | Eliquis |
| Paratek Pharmaceuticals, INC. | $35.51 | 2022-2023 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parth Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.